Challa Abhinay, Markham Ryan, Walters Darren
Department of Cardiology, Prince Charles Hospital, Chermside, Queensland, Australia.
The Prince Charles Hospital, Brisbane, Queensland, Australia.
BMJ Case Rep. 2017 Aug 2;2017:bcr-2017-221104. doi: 10.1136/bcr-2017-221104.
Here, we describe a case of a successful percutaneous insertion of a transcatheter 29 mm Edwards Sapien XT valve into a tricuspid valve in a patient with repaired tetralogy of fallot.Similar procedures have been performed with the Edwards Sapien valve and Melody valves; however, this is the first case described in the literature of an Edwards Sapien valve used in a patient with Tetralogy of Fallot.With procedural safety being demonstrated, this case illustrates an important alternative treatment option for patients with congenital heart disease. Although long-term data is required to compare its efficacy with surgically replaced valves, percutaneous procedures can serve as a delay to surgical valve replacement which over a patients' lifetime with congenital heart disease, can minimise the amount of invasive surgeries and potential complications.
在此,我们描述了一例成功经皮将29毫米爱德华兹Sapien XT经导管瓣膜植入法洛四联症修复术后患者三尖瓣的病例。使用爱德华兹Sapien瓣膜和旋律瓣膜也进行过类似手术;然而,这是文献中首次描述将爱德华兹Sapien瓣膜用于法洛四联症患者的病例。随着手术安全性得到证实,该病例为先天性心脏病患者说明了一种重要的替代治疗选择。尽管需要长期数据来将其疗效与手术置换瓣膜进行比较,但经皮手术可作为手术瓣膜置换的延迟手段,在先天性心脏病患者的一生中,可将侵入性手术的数量和潜在并发症降至最低。